Diabetes Partnering 2007-2012

Document Sample
Diabetes Partnering 2007-2012 Powered By Docstoc
					qwertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfgh
jklzxcvbnmqwertyuiopasdfghjklzxcvb
nmqwertyuiopasdfghjklzxcvbnmqwer
tyuiopasdfghjklzxcvbnmqwertyuiopas
dfghjklzxcvbnmqwertyuiopasdfghjklzx
           Diabetes Partnering 2007-2012

cvbnmqwertyuiopasdfghjklzxcvbnmq
                         To Know More...

wertyuiopasdfghjklzxcvbnmqwertyuio
pasdfghjklzxcvbnmqwertyuiopasdfghj
klzxcvbnmqwertyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwerty
uiopasdfghjklzxcvbnmqwertyuiopasdf
ghjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmrty
uiopasdfghjklzxcvbnmqwertyuiopasdf
ghjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmqw
ertyuiopasdfghjklzxcvbnmqwertyuiop
Diabetes Partnering 2007-2012

 Bharat Book introduces a report " Diabetes Partnering 2007-2012 " The report provides an analysis of
diabetes partnering deals. The majority of deals are discovery or development stage.

 The Diabetes Partnering 2007-2012 report provides understanding and access to the diabetes
partnering deals and agreements entered into by the worlds leading healthcare companies.
 * Trends in diabetes partnering deals
 * Top diabetes deals by value
 * Deals listed by company A-Z, industry sector, stage of development, technology type
 http://www.bharatbook.com/healthcare-market-research-reports/diabetes-partnering-2007-2012.html

 Description
 The Diabetes Partnering 2007-2012 provides understanding and access to the diabetes partnering deals
and agreements entered into by the worlds leading healthcare companies.

 The report provides an analysis of diabetes partnering deals. The majority of deals are discovery or
development stage whereby the licensee obtains a right or an option right to license the licensors
diabetes technology. These deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.

 Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight
into the negotiation process in terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the
detail in terms of how payments are triggered – contract documents provide this insight where press
releases do not.

 This data driven report contains over 500 links to online copies of actual diabetes deals and contract
documents as submitted to the Securities Exchange Commission by companies and their partners,
where available. Contract documents provide the answers to numerous questions about a prospective
partner’s flexibility on a wide range of important issues, many of which will have a significant impact
on each party’s ability to derive value from the deal.

 The initial chapters of this report provide an orientation of diabetes partnering trends.
 Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in
diabetes partnering since 2007, including a summary of deals by industry sector, stage of development,
deal type, and technology type. Numerous tables provide outline financial trends.

 Chapter 3 provides an overview of the leading diabetes deals since 2007. Deals are listed by headline
value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract
published at the SEC a link provides online access to the contract.

 Chapter 4 provides a comprehensive directory of diabetes partnering deals signed and announced since
2007. The chapter is organized by company A-Z, stage of development at signing, deal type
(collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via
Weblink to an online version of the deal record, and where available the contract document, providing
easy access to each contract document on demand.

 In conclusion, this report provides everything a prospective dealmaker needs to know about partnering
in the
 research, development and commercialization of diabetes technologies and products.

 Report scope
 Diabetes Partnering 2007-2012 is intended to provide the reader with an in-depth understanding and
access to diabetes trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:
Trends in diabetes dealmaking in the biopharma industry since 2007
Access to summary headline, upfront, milestone and royalty data
The leading diabetes deals by value since 2007

In Diabetes Partnering 2007-2012, the available deals are listed by:
* Headline value
* Upfront payment value
* Royalty rate value
* Company A-Z
* Industry sector
* Stage of development at signing
* Deal component type
* Technology type

For more information kindly visit :
Diabetes Partnering 2007-2012

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
Our Blogs: http://in.linkedin.com/in/bharatbook
http://healthcareraj.blogspot.com/
Follow:

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:3
posted:7/14/2012
language:
pages:3
Description: Bharat Book introduces a report " Diabetes Partnering 2007-2012 " The report provides an analysis of diabetes partnering deals. The majority of deals are discovery or development stage